Clinical Trial Update: A Study to Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic Retinopathy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of RG7774 in adults with type 1 or type 2 diabetes and treatment-naive diabetic retinopathy has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Drugs mentioned

• RG7774 (RG7774)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diabetic Retinopathy | Phase 2 | Status: COMPLETED | Results posted: 2024-09-25